Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.95
Vera Therapeutics, Inc. shareholders approved Ratification of the Selection of KPMG LLP as the independent registered public accounting firm at the 2024-05-15 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2024-05-15
Exact text from the filing
Proposal 2. Ratification of the Selection of Independent Registered Public Accounting Firm The Company’s stockholders ratified the selection by the Audit Committee of the Company’s Board of Directors of KPMG LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2024.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Vera Therapeutics, Inc. shareholders approved Election of Directors at the 2024-05-15 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2024-05-15
Exact text from the filing
Proposal 1. Election of Directors The Company’s stockholders elected the three persons listed below as Class III Directors, each to serve until the Company’s 2027 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified, or, if sooner, such director’s death, resignation or removal.
View on SEC.gov